Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pharmacotherapy for anxiety disorders and comorbid alcohol dependency

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD007505Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 octubre 2008see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Don Wilson

    Correspondencia a: Department of Psychiatry and Mental Health, Groote Schuur Hospital, Cape Town, South Africa

    [email protected]

  • Jonathan C Ipser

    MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

  • Dan J Stein

    Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa

Contributions of authors

Don Wilson helped coordinate the protocol and contributed towards the background section. Dan Stein conceived the idea of the review, and provided feedback on the draft version of the protocol. Jonathan Ipser provided input on the methodological components of the protocol and stands a guarantor of the review.

Sources of support

Internal sources

  • University of Cape Town, Cape Town, South Africa.

External sources

  • MRC Research Unit on Anxiety and Stress Disorders, South Africa.

Declarations of interest

The MRC Unit on Anxiety Disorders has been supported by each of the pharmaceutical companies with an interest in psychiatry in South Africa.

Potential conflicts of interest for individual reviewers

Don Wilson is employed by the University of Cape Town and the Western Cape Provincial government. As part of his duties he occasionally conducts clinical trials, some of which may are funded by pharmaceutical companies (including GlaxoSmithKline and Organon). He has presented on behalf of Synofi‐Synthelabo and Eli Lilly in the past.

Jonathan Ipser has no known conflicts of interest.

Dan Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli‐Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth. He has participated in a number of ongoing trials, and has presented data from some of these trials on behalf of the sponsoring companies.

Version history

Published

Title

Stage

Authors

Version

2015 Jan 20

Pharmacotherapy for anxiety and comorbid alcohol use disorders

Review

Jonathan C Ipser, Don Wilson, Taiwo O Akindipe, Carli Sager, Dan J Stein

https://doi.org/10.1002/14651858.CD007505.pub2

2008 Oct 08

Pharmacotherapy for anxiety disorders and comorbid alcohol dependency

Protocol

Don Wilson, Jonathan C Ipser, Dan J Stein

https://doi.org/10.1002/14651858.CD007505

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.